๐Ÿ”ฌDeep Research

SRPT โ€” Sarepta Therapeutics ยท catalysts, narrative & risks

ยท30 sourcesSRPT forecast โ†’

Sarepta Therapeutics (SRPT) โ€” Point-in-Time Research Summary (as of 2026-10-28)

Valuation Snapshot

As of the latest prints on October 27โ€“28, 2026, SRPT traded near ~$19โ€“20, with a market capitalization of roughly $1.9Bโ€“$2.0B, and a 52-week range of approximately $14.68โ€“$24.68 [17], [26], [27]. The stock is down roughly 12.2% year-to-date and about 19.6% over the past year, sitting roughly mid-range on its 52-week band [17], [26], [27]. It is not part of a major index such as the S&P 500 [8].


AI-assisted research from the K3vl4r desk โ€” not personalized investment advice. More research โ†’